Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGlu)-poly(DLAla)--poly(LLys). II. Evidence for a T-T-cell collaboration in delayed-type hypersensitivity responses and for a T-cell defect at the efferent phase in nonresponder H-2k mice.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMC 2185810)

Published in J Exp Med on March 01, 1980

Authors

G Strassmann, Z Eshhar, E Mozes

Articles cited by this

A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44

Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16

Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice. J Exp Med (1965) 7.27

Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J Exp Med (1978) 6.29

Studies on the chemical basis of the antigenicity of proteins. 5. Synthesis, characterization and immunogenicity of some multichain and linear polypeptides containing tyrosine. Biochem J (1962) 4.82

Two distinct types of helper T cells involved in the secondary antibody response: independent and synergistic effects of Ia- and Ia+ helper T cells. J Exp Med (1978) 3.80

Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses. J Exp Med (1976) 3.21

A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64

T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22

Antigenicity: some molecular aspects. Science (1969) 1.98

Ly phenotype of T cells cytotoxic for syngeneic mouse mammary tumors: evidence for T cell interactions. Proc Natl Acad Sci U S A (1977) 1.65

T-lymphocyte-enriched murine peritoneal exudate cells. IV. Genetic control of cross-stimulation at the T-cell level. J Exp Med (1977) 1.40

In vitro and in vivo induction of effector T cells mediating DTH responses to a protein and a synthetic polypeptide antigen. Cell Immunol (1979) 1.38

Histocompatibility linked immune responsiveness and restrictions imposed on sensitized lymphocytes. J Exp Med (1977) 1.24

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process. J Exp Med (1980) 1.11

T-T cell collaboration in rejection of a syngeneic SV40-induced sarcoma in mice. Nature (1978) 0.89

Articles by these authors

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. Proc Natl Acad Sci U S A (1989) 4.63

Transport of 3-o-Methylglucose Into and Out of Storage Cells of Daucus carota. Plant Physiol (1968) 3.05

Dependence of the chemical nature of antibodies on the net electrical charge of antigens. Proc Natl Acad Sci U S A (1966) 2.25

Antigen-specific thymus cell factors in the genetic control of the immune response to poly-(tyrosyl, glutamyl)-poly-D, L-alanyl--poly-lysyl. J Exp Med (1974) 2.19

Generation of hybridomas secreting murine reaginic antibodies of anti-DNP specificity. J Immunol (1980) 2.14

Radiation therapy for the prevention of heterotopic ossification at the elbow. J Bone Joint Surg Br (2001) 2.12

Antigen-specific T-cell factors in the genetic control of the immune response to poly(Tyr,Glu)-polyDLAla--polyLys. Evidence for T- and B-cell defects in SJL mice. J Exp Med (1975) 1.98

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A (1988) 1.91

Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor. Proc Natl Acad Sci U S A (1981) 1.87

Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus. J Virol (1991) 1.83

Variability and repertoire size of T-cell receptor V alpha gene segments. Nature (1985) 1.81

Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med (1983) 1.79

In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. Cancer Res (1995) 1.76

Contribution of different cell types to the genetic control of immune responses as a function of the chemical nature of the polymeric side chains (poly-L-prolyl and poly-DL-alanyl) of synthetic immunogens. J Exp Med (1972) 1.75

The nature of the antigenic determinant in a genetic control of the antibody response. J Exp Med (1969) 1.74

Detection of a cytokeratin determinant common to diverse epithelial cells by a broadly cross-reacting monoclonal antibody. EMBO J (1982) 1.63

Inhibition of IgE binding to mast cells and basophils by monoclonal antibodies to murine IgE. Eur J Immunol (1984) 1.58

The genetic control of antibody specificity. J Exp Med (1969) 1.58

In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. J Clin Invest (1988) 1.57

The beneficial effect of the estrogen antagonist, tamoxifen, on experimental systemic lupus erythematosus. J Rheumatol (1994) 1.56

Thymus-independence of slowly metabolized immunogens. Proc Natl Acad Sci U S A (1972) 1.52

Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood (1996) 1.51

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther (2000) 1.46

Reorganization of arrays of prekeratin filaments during mitosis. Immunofluorescence microscopy with multiclonal and monoclonal prekeratin antibodies. Exp Cell Res (1981) 1.43

Ferritin, a Hodgkin's disease associated antigen. Proc Natl Acad Sci U S A (1974) 1.43

In vitro and in vivo induction of effector T cells mediating DTH responses to a protein and a synthetic polypeptide antigen. Cell Immunol (1979) 1.38

Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity. Transplant Proc (1989) 1.36

Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro. Proc Natl Acad Sci U S A (1981) 1.36

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain. J Exp Med (1993) 1.35

Genetic control of immune responses. Curr Top Microbiol Immunol (1972) 1.34

Induction of secretion of IgM from cells of the B cell line 38c-13 by somatic cell hybridization. J Immunol (1979) 1.32

Contribution of bone marrow cells and lack of expression of thymocytes in genetic controls of immune responses for two immunopotent regions within poly-(Phe,Glu)-poly-Pro--poly-Lys in inbred mouse strains. J Exp Med (1971) 1.31

Cellular basis of the genetic control of immune responses to synthetic polypeptides. I. Differences in frequency of splenic precursor cells specific for a synthetic polypeptide derived from multichain polyproline ((T,G)-Pro--L) in high and low responder inbred mouse strains. J Exp Med (1970) 1.31

Monoclonal antibodies to human interferon-gamma: production, affinity purification and radioimmunoassay. EMBO J (1983) 1.31

Monoclonal antibodies to human alpha-interferon and their use for affinity chromatography. J Immunol (1982) 1.30

The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum (1989) 1.28

catELISA: a facile general route to catalytic antibodies. Proc Natl Acad Sci U S A (1993) 1.26

The role of thymus cells in the immune response to poly(Tyr, Glu)-polyD L Ala--polyLys as a function of the genetic constitution of the mouse strain. Eur J Immunol (1974) 1.24

Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis (2005) 1.24

Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24

Affinity chromatography of human fibroblast interferon (IFN-beta 1) by monoclonal antibody columns. J Gen Virol (1983) 1.20

Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3'-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol (1996) 1.19

T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor. Nature (1980) 1.19

Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol (1995) 1.18

Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies. Immunol Rev (1982) 1.18

Thymus independence of a collagen-like synthetic polypeptide and of collagen, and the need for thymus and bone marrow-cell cooperation in the immune response to gelatin. J Exp Med (1974) 1.15

LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas. Nature (1982) 1.15

Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process. J Exp Med (1980) 1.11

A ceramide analogue inhibits T cell proliferative response through inhibition of glycosphingolipid synthesis and enhancement of N,N-dimethylsphingosine synthesis. Biochemistry (1990) 1.10

The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice. Eur J Immunol (1989) 1.10

Resolution of mouse and human immunoglobulin G into two fractions by chromatography on diethylaminoethyl-sephadex. Relation of mouse antibody type to the antigen charge. Isr J Med Sci (1969) 1.10

Immune response of mice to nucleic acids: strain-dependent differences in magnitude and class of antibody production. J Immunol (1973) 1.10

Antibody response of inbred mouse strains to ordered tetrapeptides of tyrosine and glutamic acid attached to multichain polyalanine or polyproline. Tyr-Tyr-Glu-Glu is a major determinant of the random poly-(Tyr, Glu)-polyDLAla--polyLys. J Exp Med (1974) 1.09

Activation of T and B lymphocytes in vitro. VI. Biochemical and physicochemical characterization of the allogeneic effect factor. J Immunol (1977) 1.09

Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures. J Immunol (1983) 1.08

Analysis of the biological functions and fine specificity of (T,G)-A--L specific T cell clones. Immunobiology (1986) 1.08

Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE. FASEB J (1990) 1.06

Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol (1995) 1.06

The effect of genetic control of immune response to synthetic polypeptides on the response to homologous DNP-polypeptide conjugates. Immunochemistry (1969) 1.05

The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit. Immunology (1990) 1.05

[Strain-dependent differences in the specificity of antibody responses toward lysozyme]. J Immunol (1971) 1.04

Role of antigenic structure in cell to cell cooperation. Proc Natl Acad Sci U S A (1976) 1.04

Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol (2000) 1.03

The nature of murine immune response to nucleic acids. J Immunol (1975) 1.03

Linkage between immune response potential to DNA and X chromosome. Nature (1974) 1.03

Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol (2002) 1.02

Cellular basis of the genetic control of immune responses to synthetic polypeptides. II. Frequency of immunocompetent precursors specific for two distinct regions within (Phe, G)-Pro--L, a synthetic polypeptide derived from multichain polyproline, in inbred mouse strains. J Exp Med (1971) 1.02

Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol (1997) 1.01

Antigen-specific T cell factors: a fine analysis of specificity. J Immunol (1977) 1.01

In vitro correction of antigen-induced immune suppression: effects of histamine, dibutyryl cyclic AMP and cholera enterotoxin. Cell Immunol (1974) 1.01

Antigen specific T-cell helper factor cross reacts idiotypically with antibodies of the same specificity. Nature (1979) 1.01

IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes. Cell Immunol (1996) 1.01

Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10. J Immunol (1995) 1.01

The genetic regulation of the induction of experimental SLE. Immunology (1990) 1.00

Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Proc Natl Acad Sci U S A (1997) 1.00

Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors. J Immunol (1993) 1.00

(T,G)-A-L specific immune response potential and HLA typing of Israeli patients with systemic lupus erythematosus. Clin Exp Immunol (1985) 0.99

Metastatic properties conferred on nonmetastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst (1981) 0.99

Cross-reactive idiotypic determinants on murine anti-(T,G)-A--L antibodies. J Immunol (1978) 0.99

A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses. Proc Natl Acad Sci U S A (1997) 0.99

In vitro studies on H-2 linked unresponsiveness. 1. Normal helper cells to (T,G)-A-L and GAT in low and non-responder mice. Immunology (1977) 0.99

Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse. J Immunol (1999) 0.99

The role of thymocytes and bone marrow cells in defining the response to the dinitrophenyl hapten attached to positively and negatively charged synthetic polypeptide carriers. Cell fractionation over charged columns. J Exp Med (1973) 0.99

Crystal structure of a catalytic antibody Fab with esterase-like activity. Structure (1994) 0.99

Cellular aspects of the inverse relationship between the net charge of immunogens of antibodies elicited. Proc Natl Acad Sci U S A (1970) 0.98

The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment. Int Immunol (1995) 0.98

The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc Natl Acad Sci U S A (2001) 0.98

Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies. Proc Natl Acad Sci U S A (1995) 0.98

Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity. Biochemistry (1990) 0.97

Recognition of human colon cancer by T cells transduced with a chimeric receptor gene. Cancer Gene Ther (2000) 0.97

Role of MHC class I molecules in autoimmune disease. Crit Rev Immunol (1997) 0.97

Antigenic competition and genetic control of the immune response. A hypothesis for intramolecular competition. Cell Immunol (1973) 0.97

The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus. Int Immunol (1993) 0.97

X-ray structures of a hydrolytic antibody and of complexes elucidate catalytic pathway from substrate binding and transition state stabilization through water attack and product release. Proc Natl Acad Sci U S A (1997) 0.97

Prophylactic endovascular radiotherapy to prevent intimal hyperplasia after stent implantation in femoropopliteal arteries. Cardiovasc Intervent Radiol (1994) 0.97